SCHEMBL4458782

SCHEMBL4458782

CCn1cc(CN2CCN(c3cncc4[nH]c(-c5ccc(C(C)(C)C)cc5)nc34)CC2)c(=O)[nH]c1=O

nearest known ligand 0.81

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GNRHR P30968 20/20 0.81
HTR2A P28223 1/20 0.81

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3275511 0.89 GNRHR (1.00) GNRHRHTR2A
SCHEMBL4465228 0.84 GNRHR (0.77) GNRHRHTR2A
SCHEMBL4460721 0.84 GNRHR (0.77) GNRHRHTR2A
SCHEMBL4471142 0.84 GNRHR (0.80) GNRHRHTR2A
SCHEMBL4475211 0.83 GNRHR (0.79) GNRHRHTR2A
SCHEMBL3274255 0.83 GNRHR (0.88) GNRHRHTR2A
SCHEMBL3275375 0.82 GNRHR (0.85) GNRHRHTR2A
SCHEMBL3275851 0.81 GNRHR (0.84) GNRHRHTR2A
SCHEMBL3274221 0.81 GNRHR (0.84) GNRHRHTR2A
SCHEMBL3275204 0.80 GNRHR (0.83) GNRHRHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582634-B2 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2009-09-01 US claimed
US-20060189616-A1 7-Substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor WYETH (US) 2006-08-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189616-A1 7-Substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor GNRHR, LHCGR, FSHR GNRHR 1/4885HTR2A 528/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.